Simone Heyn

499 total citations
16 papers, 141 citations indexed

About

Simone Heyn is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Simone Heyn has authored 16 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Simone Heyn's work include Multiple Myeloma Research and Treatments (10 papers), CAR-T cell therapy research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Simone Heyn is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), CAR-T cell therapy research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Simone Heyn collaborates with scholars based in Germany, United States and Netherlands. Simone Heyn's co-authors include Nicholas K. Gonatas, Ahmad Salehi, Dick F. Swaab, Dietger Niederwieser, Martin Mohren, Wolfram Pönisch, Thoralf Lange, Haifa Kathrin Al‐Ali, Rainer Krahl and Cornelia Becker and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Simone Heyn

13 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Heyn Germany 5 98 47 36 26 16 16 141
Bykova Ov Russia 6 51 0.5× 43 0.9× 47 1.3× 27 1.0× 13 0.8× 29 242
Vikas Bhambhani United States 7 34 0.3× 86 1.8× 11 0.3× 9 0.3× 46 2.9× 13 194
Ilaria Viganò Italy 7 16 0.2× 52 1.1× 10 0.3× 13 0.5× 26 1.6× 17 125
Alessandro Maglione Italy 9 23 0.2× 85 1.8× 15 0.4× 7 0.3× 11 0.7× 16 172
Connie T. R. M. Stumpel Netherlands 7 20 0.2× 92 2.0× 8 0.2× 13 0.5× 11 0.7× 9 197
Helene Kraus Switzerland 3 14 0.1× 25 0.5× 22 0.6× 6 0.2× 10 0.6× 3 101
Meike Wiese Germany 6 33 0.3× 177 3.8× 8 0.2× 4 0.2× 24 1.5× 8 215
Kylee J. Veazey United States 10 15 0.2× 294 6.3× 18 0.5× 14 0.5× 10 0.6× 13 366
Imma Rost Germany 9 13 0.1× 157 3.3× 10 0.3× 10 0.4× 10 0.6× 24 322
Shannon Sarros Australia 6 7 0.1× 65 1.4× 19 0.5× 7 0.3× 22 1.4× 14 144

Countries citing papers authored by Simone Heyn

Since Specialization
Citations

This map shows the geographic impact of Simone Heyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Heyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Heyn more than expected).

Fields of papers citing papers by Simone Heyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Heyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Heyn. The network helps show where Simone Heyn may publish in the future.

Co-authorship network of co-authors of Simone Heyn

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Heyn. A scholar is included among the top collaborators of Simone Heyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Heyn. Simone Heyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Vučinić, Vladan, Luise Fischer, Enrica Bach, et al.. (2023). Apheresis for Production of Chimeric Antigen Receptor (CAR) T Cells in Patients with Multiple Myeloma - Clinical Factors, Cell Composition and T Cell Senescence. Blood. 142(Supplement 1). 3521–3521. 1 indexed citations
3.
Fischer, Luise, Sandra Hoffmann, Ronny Baber, et al.. (2023). Increased Bone Turnover and Decreased BCMA Levels in Patients with Response to Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma. Blood. 142(Supplement 1). 6643–6643. 1 indexed citations
4.
Franke, Georg‐Nikolaus, Simone Heyn, Enrica Bach, et al.. (2022). Analysis of stem cell collections in adult patients with Ewing sarcoma. Transfusion. 62(8). 1612–1618.
5.
Merz, Maximilian, Vladan Vučinić, Simone Heyn, et al.. (2022). Rapid Response to Idecabtagene Vicleucel in a Myeloma Patient Refractory to Multiple Prior Lines of Anti-BCMA Directed Therapies. Blood. 140(Supplement 1). 12492–12493.
6.
Gockel, Ines, et al.. (2021). Epigastrische Schmerzen beim „Magentumor“. Der Chirurg. 93(4). 395–398. 1 indexed citations
7.
Heyn, Simone, Cornelia Becker, Christian Pfrepper, et al.. (2017). Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV). Journal of Cancer Research and Clinical Oncology. 143(10). 2049–2058. 4 indexed citations
8.
Heyn, Simone, Christian Pfrepper, Georg‐Nikolaus Franke, et al.. (2015). Successful Treatment of Patients With Newly Diagnosed/Untreated Light Chain Multiple Myeloma With a Combination of Bendamustine; Prednisone and Bortezomib (BPV). Clinical Lymphoma Myeloma & Leukemia. 15. e167–e168. 2 indexed citations
9.
Iacobelli, Simona, Sabine Leiblein, Ann‐Kathrin Eisfeld, et al.. (2013). Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia. Leukemia & lymphoma. 55(6). 1274–1280. 3 indexed citations
10.
Pönisch, Wolfram, Simone Heyn, Ina Wagner, et al.. (2013). Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO – #077. British Journal of Haematology. 162(2). 202–209. 22 indexed citations
11.
Heyn, Simone, Nadja Jäkel, Robert Rohrberg, et al.. (2012). Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma. Blood. 120(21). 1855–1855. 2 indexed citations
12.
Pönisch, Wolfram, Simone Heyn, Ina Wagner, et al.. (2010). Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial. Blood. 116(21). 1971–1971. 2 indexed citations
14.
Hudecek, Michael, Nadja Jäkel, Simone Heyn, et al.. (2008). Spontaneous Remission of Acute Myeloid Leukemia Relapse after Hematopoietic Cell Transplantation in a High-Risk Patient with 11q23/MLL Abnormality. Acta Haematologica. 119(2). 111–114. 3 indexed citations
15.
Heyn, Simone, Nadja Jaekel, Robert Rohrberg, et al.. (2007). Bortezomib in Combination with Bendamustine and Prednisone in the Treatment of Patients with Refractory/Relapsed Multiple Myeloma.. Blood. 110(11). 2723–2723. 8 indexed citations
16.
Salehi, Ahmad, Simone Heyn, Nicholas K. Gonatas, & Dick F. Swaab. (1995). Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by smaller Golgi apparatus. Neuroscience Letters. 193(1). 29–32. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026